Yaou Liu1, Jinhui Wang2, Marita Daams2, Florian Weiler2, Horst K Hahn2, Yunyun Duan2, Jing Huang2, Zhuoqiong Ren2, Jing Ye2, Huiqing Dong2, Hugo Vrenken2, Mike P Wattjes2, Fu-Dong Shi2, Kuncheng Li1, Frederik Barkhof2. 1. From the Departments of Radiology (Y.L., Y.D., J.H., Z.R., K.L.) and Neurology (J.Y., H.D.), Xuanwu Hospital, Capital Medical University, Beijing, China; the Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam (Y.L., M.D., H.V., M.P.W., F.B.), and the Department of Anatomy and Neurosciences, Section of Clinical Neuroscience (M.D.), VU University Medical Center, Amsterdam, the Netherlands; the Department of Neurology and Tianjin Neurological Institute (Y.L., F.-D.S.), Tianjin Medical University, General Hospital, China; the Center for Cognition and Brain Disorders (J.W.), Hangzhou Normal University; Zhejiang Key Laboratory for Research in Assessment of Cognitive Impairments (J.W.), Hangzhou, China; and Fraunhofer MEVIS (F.W., H.K.H.), Institute for Medical Image Computing, Bremen, Germany. asiaeurope80@gmail.com kunchengli55@gmail.com. 2. From the Departments of Radiology (Y.L., Y.D., J.H., Z.R., K.L.) and Neurology (J.Y., H.D.), Xuanwu Hospital, Capital Medical University, Beijing, China; the Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam (Y.L., M.D., H.V., M.P.W., F.B.), and the Department of Anatomy and Neurosciences, Section of Clinical Neuroscience (M.D.), VU University Medical Center, Amsterdam, the Netherlands; the Department of Neurology and Tianjin Neurological Institute (Y.L., F.-D.S.), Tianjin Medical University, General Hospital, China; the Center for Cognition and Brain Disorders (J.W.), Hangzhou Normal University; Zhejiang Key Laboratory for Research in Assessment of Cognitive Impairments (J.W.), Hangzhou, China; and Fraunhofer MEVIS (F.W., H.K.H.), Institute for Medical Image Computing, Bremen, Germany.
Abstract
OBJECTIVE: To investigate spinal cord and brain atrophy in neuromyelitis optica (NMO), and its relationship with other MRI measurements and clinical disability, compared with patients with multiple sclerosis (MS) and healthy controls (HC). METHODS: We recruited 35 patients with NMO, 35 patients with MS, and 35 HC, who underwent both spinal cord and brain MRI. Mean upper cervical cord area (MUCCA), brain parenchymal fraction (BPF), gray matter fraction (GMF), white matter fraction (WMF), and spinal cord and brain lesion loads were measured and compared among groups. Multivariate associations between MUCCA and brain volume measurement and clinical variables were assessed by partial correlations and multiple linear regression. RESULTS: Patients with NMO showed smaller MUCCA than HC (p = 0.004), and patients with MS had a trend of smaller MUCCA compared to HC (p = 0.07), with no significant difference between the patient groups. Patients with NMO showed lower BPF than HC, and patients with MS had lower BPF and GMF than patients with NMO. In NMO, MUCCA was correlated with Expanded Disability Status Scale score (EDSS), number of relapses, and total spinal cord lesion length, while in MS, MUCCA was correlated with WMF and EDSS. MUCCA was the only independent variable for predicting clinical disability measured by EDSS in NMO (R(2) = 0.55, p < 0.001) and MS (R(2) = 0.17, p = 0.013). CONCLUSION: NMO showed predominately spinal cord atrophy with mild brain atrophy, while MS demonstrated more brain atrophy, especially in the gray matter. MUCCA is the main MRI-derived parameter for explaining clinical disability in NMO and MS, and may serve as a potential biomarker for further clinical trials, especially in NMO.
OBJECTIVE: To investigate spinal cord and brain atrophy in neuromyelitis optica (NMO), and its relationship with other MRI measurements and clinical disability, compared with patients with multiple sclerosis (MS) and healthy controls (HC). METHODS: We recruited 35 patients with NMO, 35 patients with MS, and 35 HC, who underwent both spinal cord and brain MRI. Mean upper cervical cord area (MUCCA), brain parenchymal fraction (BPF), gray matter fraction (GMF), white matter fraction (WMF), and spinal cord and brain lesion loads were measured and compared among groups. Multivariate associations between MUCCA and brain volume measurement and clinical variables were assessed by partial correlations and multiple linear regression. RESULTS:Patients with NMO showed smaller MUCCA than HC (p = 0.004), and patients with MS had a trend of smaller MUCCA compared to HC (p = 0.07), with no significant difference between the patient groups. Patients with NMO showed lower BPF than HC, and patients with MS had lower BPF and GMF than patients with NMO. In NMO, MUCCA was correlated with Expanded Disability Status Scale score (EDSS), number of relapses, and total spinal cord lesion length, while in MS, MUCCA was correlated with WMF and EDSS. MUCCA was the only independent variable for predicting clinical disability measured by EDSS in NMO (R(2) = 0.55, p < 0.001) and MS (R(2) = 0.17, p = 0.013). CONCLUSION: NMO showed predominately spinal cord atrophy with mild brain atrophy, while MS demonstrated more brain atrophy, especially in the gray matter. MUCCA is the main MRI-derived parameter for explaining clinical disability in NMO and MS, and may serve as a potential biomarker for further clinical trials, especially in NMO.
Authors: Arman Eshaghi; Viktor Wottschel; Rosa Cortese; Massimiliano Calabrese; Mohammad Ali Sahraian; Alan J Thompson; Daniel C Alexander; Olga Ciccarelli Journal: Neurology Date: 2016-11-02 Impact factor: 9.910